Study: Firms “underinvest” in long

MIT NewsStudy: Firms “underinvest” in long-term cancer research | MIT NewsMIT NewsThe social cost is significant: The researchers estimate that the lack of investment in longer-term drugs resulted in a loss of 890,000 life-years among people diagnosed with cancer in the year 2003 alone. The paper also suggests three policy ...and more »

Share this post